MediPal Holdings Corporation
MAHLY
Other OTC19.00
USD
- -
- -
ISIN
US58502T1079
CUSIP
58502T107
Return %
Stock
S&P500
1Y
27.09
26.53
3Y
20.33
76.60
5Y
-3.89
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Shuichi Watanabe
- Full Time Employees
- 13,075
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Address
- 2-7-15, Yaesu Tokyo Japan 104-8461
- IPO Date
- Oct 6, 2009
- Website
- medipal.co.jp
- Similar Companies
- Business
- MediPal Holdings Corporation, a holding company listed on the Tokyo Stock Exchange Prime Market (ticker: 7459; OTC: MAHLY), oversees group companies engaged in the wholesale distribution of pharmaceuticals, cosmetics, daily necessities, over-the-counter drugs, animal health products, and food processing raw materials across Japan. Its operations span three primary segments: the Prescription Pharmaceutical Wholesale Business, which procures and distributes prescription drugs, healthcare products for diagnostics, testing, treatment and administration including medical equipment, medical materials, and clinical diagnostic reagents to hospitals, clinics, and dispensing pharmacies; the Cosmetics, Daily Necessities and OTC Pharmaceutical Wholesale Business, which supplies cosmetics, daily necessities, and OTC pharmaceuticals to drugstores, home centers, convenience stores, and supermarkets; and the Animal Health Products and Food Processing Raw Materials Wholesale Business, which provides animal health products to veterinary clinics, farms, agricultural cooperatives, and processed food manufacturers, alongside raw ingredients for food processing. The company also supports healthcare services such as contract-based epidemiological and clinical studies, health insurance claims reviews, medical coding dispatch, outsourcing, remote education, and maintenance of computerized medical supply and master product databases for medical facilities; it operates through a nationwide network of over 300 bases from Hokkaido to Okinawa, targeting healthcare providers, retailers, and industrial customers primarily in Japan. Founded on October 8, 1898, and headquartered at 3-1-1 Kyobashi, Chuo-ku, Tokyo 104-8461 Japan, MediPal Holdings employs 13,061 consolidated staff as of March 31, 2025, with key subsidiaries including MEDICEO Corporation for prescription wholesaling, PALTAC Corporation for cosmetics and OTC, MEDIPAL FOODS CORPORATION for food materials, MP Gokyo Food & Chemical Co., Ltd., PRESUSCUBE Corporation for digital pharmacy management support, PreMedica Inc., FloraDiscovery Inc., Toshichi Inc., and others. Recent developments include the July 2024 additional investment making PRESUSCUBE Corporation a consolidated subsidiary to enhance digital transformation services for insurance pharmacies via tools like BHI management analysis and PRESUS business support systems, leveraging group logistics and networks; May 2024 acquisitions of PreMedica Inc. and FloraDiscovery Inc. as wholly owned subsidiaries; the September 2025 global licensing and Japan co-development deal with JCR Pharmaceuticals for JR-479; and ongoing equity buyback tranches under the May 2025 plan, aligning with the 2027 Medium-Term Vision for business innovation and growth in digital and healthcare efficiency.